Latest / The Fourcast Media Podcast Network / Conquering Cancer in the African American Community with Fitzroy Dawkins | Stop Look & Listen
Transcript
- 0:01Pushpod dot Com. Ladies and gentlemen, thank you for tuning in to this
- 0:08week's edition to stop looking listen. I'm your host, the Troy Gardner.
- 0:13This week we have a special guest. We have a medical oncologist enhematologist with
- 0:20over thirty years as an academic in biotech executive. He currently serves as a
- 0:26principal clinical consultant at Data Revive. We have doctor Fitzroy Dawkins. Welcome to
- 0:33the show, Doctor Dawkins, Detroit. Thank you for having me. I
- 0:36look forward to talking with you, and thanks again for the invite. Thanks.
- 0:40Oh sure, sure. I mean it's it's always important, especially on
- 0:44this platform, to touch on issues that are meaningful to our community, and
- 0:51I think this conversation will accomplish that goal. Okay, I hope, certain
- 0:55hope. So I certain hope. I can't help in that regard, all
- 0:58right, cool, So, like, just take us on. I'm a
- 1:00fantastic voyage into the childhood of a young doctor Dawkins. Oh wow, So
- 1:08very briefly, I I grew up in the in the Western is in the
- 1:14Islands, as they say, specifically in Jamaica, pretty much a country boy.
- 1:19Mom is a nurse there and trained in the UK as a nurse,
- 1:26came back home and over the time I saw her work and her commitment to
- 1:37her patients, commitment to the community where she was a nurse, the doctor,
- 1:42the dentist, the everything in the bushes, so to speak. Onto
- 1:46the doctor showed up and that made a tremendous impact on me. The other
- 1:52impact that I had in terms of my journey towards becoming a doctor is that
- 1:57I was really sick as a kid. For between the ages of ten through
- 2:01eleven twelve years old, I was really quite sick and they couldn't quite figure
- 2:06out what was wrong with me. And I spent a heck of a lot
- 2:09of time in the hospital there and an adult what as a young boy ten
- 2:15eleven years old, where I witnessed quite a bit of things. But in
- 2:22the process of being in the hospital for a five month stint, at times
- 2:28I had a tremendous doctor, doctor doctor Golding, John Golding, he's a
- 2:38surgeon, was from the UK, but he came and he took great care
- 2:45of me, and I noticed, even as a child, how careful he
- 2:47was and how caring he was. So just to give you a little bit
- 2:52of a background, because Jamaica is part of the British system, the British
- 2:55Commonwealth. For me at the time time to go to high school, I
- 3:01had to win a national scholarship. I had to sit an exam. I
- 3:05had to win a national scholarship, and at the time that I was in
- 3:08the hospital was a time that I had to sit that scholarship. And if
- 3:12I missed that opportunity, I may never go to high school because my folks
- 3:15just didn't have that kind of funds to send me to a private high school.
- 3:20And in the process of taking care of me, he looked at the
- 3:23social work and said, you know, isn't this boy supposed to be sit
- 3:28in the common entrance? Is what it's just called. And she said yes,
- 3:31and he said, see what you can do for him, because the
- 3:35time has passed, and she looked into it. She reached out to the
- 3:40Ministry of Education in Jamaica and they allowed me to sit that examination all by
- 3:46myself. After all my colleagues wrote the nation to nation. I finished the
- 3:51examinations and I passed it, thank god. And I went on to a
- 3:57very good high school, Manchester High School and then Wilma's Boys School, so
- 4:02that was the second piece for me, the fact that he did such a
- 4:06great job of taking care of me and that he saw me beyond just a
- 4:11patient. The other piece for me is that I learned science. I loved
- 4:15science. I loved the whole idea of science and delving into science and biology
- 4:21and physics and chemistry. So that's a big influence as well. The other
- 4:28influence for me was I became a Christian at fourteen, and I began to
- 4:33think about what that means, what does that mean practically in terms of in
- 4:40terms of my journey through life. And I thought, combining those factors together,
- 4:46that becoming a physician was perhaps the best thing for me. And you
- 4:50coupled that with the fact that I saw some really horrific things as a child
- 4:55in the hospital. One example I saw at an outlying hospital where I was
- 5:00placed is that there was one doctor for the whole hospital one and one weekend
- 5:08when it was his weekend to be off, and no one to cover him.
- 5:12I saw somebody literally dying in front of my eyes in the hospital after
- 5:17motivehicle accident. The nurses couldn't help him. They did what they could,
- 5:20but he died. There was no doctor to take him to surgery, and
- 5:24I thought, my god, I must be able to do something about this.
- 5:30And so those are some sort of pivotal moments in my life that combined
- 5:33that made me decide that becoming a physician was the right thing for me.
- 5:38So thanks for the question. Oh sure, I mean, you definitely answered
- 5:43the question I had in mind. Next, was that moment where that calling
- 5:47started the fester and whether you answered it immediately, did you have any thoughts
- 5:53of deviating and going in another direction or you knew immediately that this is what
- 5:59you wanted to practice? Well, you know, so, again, that's
- 6:02an interesting question and very insightful because so here I was fourteen, fifteen,
- 6:08sixteen, and in Jamaica at the time, you could finish high school at
- 6:12sixteen or seventeen years old. And I the other path that I thought about,
- 6:16quite honestly, was becoming a pastor. So in some ways sort of
- 6:21the two things are sort of overlapping each other in so many ways. Is
- 6:26caring for people, caring for the community, And I struggled with that,
- 6:30but I thought, you know, maybe becoming a physician might be a better
- 6:33path for me. And so those were the two, you know, dominant
- 6:40thoughts in my mind. The third, if there was ever one, was
- 6:44I loved history. I still love history. I had a teacher. It
- 6:46was a tremendous inference on me from in teaching me history, and so I
- 6:53thought at times, maybe maybe I could become a history professor. So I
- 6:58told you that idea. But I thought, from a practical standpoint, what
- 7:01I thought the country needed was to have doctors who could take care of patients
- 7:10and be perhaps a substitute for that one doctor who was the only doctor in
- 7:14that hospital for lord knows how many years. So those are the three prongs
- 7:20that I considered. But I landed on being a physician, and I've never
- 7:24regretted it. Right, So, did you stay on the homeland in Jamaica
- 7:30to practice or like, when did you make your way here to the United
- 7:33States? So I made my way to answer the question directly, I made
- 7:40my way to New York City as an eighteen year old, a very reluctant
- 7:48eighteen year old. I mean, this is Jamaica. There's sunshine, there's
- 7:53beaches, there's things to do, fun things for a young man to do.
- 7:59And I had a let's say, I had a meaningful conversation with my
- 8:05mother over the course of many months, and she decided I should go to
- 8:09the United States, and I decided I was not going to go to the
- 8:13United States. Why would I want to leave Jamasia. So it was a
- 8:16tussle. But at eighteen, post high school, I landed at Kennedy Airport
- 8:22and began that journey that my mother thought was the best one for me.
- 8:28Okay, all right, So as a seasoned academic and biotech executive, like,
- 8:33just talk about how you balance those roles when it comes to clinical practice,
- 8:39research and industry leadership. All right, thanks for that. So a
- 8:43little bit of history again, As I said, I'm obsessed about history,
- 8:46so I want to give you a little bit of the background. So I
- 8:52went to college in New York City City, University of New York, one
- 8:56of your college specifically. I then went to Buffalo Medical School in Buffalo,
- 9:03New York for my medical school and my residency. And then I left there
- 9:09and went to George Washington University for my fellowship in hematology oncology, and then
- 9:16I went Acrosstown to Howard University. Because I looked at a number of places,
- 9:22I looked at the University of Maryland to become an academic, and I
- 9:24looked at Howard and I thought, how does a better choice for me?
- 9:28I got here. I spent fourteen years there, and it was some of
- 9:31the most exciting years of my life because in the process of going to Howard,
- 9:37having been turned down by the medical established in Jamaica from coming back home
- 9:43to give off my services, I felt that I owed African American community a
- 9:48special debt of gratitude for the path that they created for me to come from
- 9:54someplace else as a black man and to go to medical school. So how
- 10:00was that perfect outlet for me? And so the idea of training the next
- 10:05generation of black physicians, primarily black physicians, the idea of caring for patients
- 10:13who were on the front lines before I got to this country was a meaningful
- 10:20piece for me. The other piece was the recognition that cancer was it is
- 10:28still a deadly disease and more research needs to be done, and I felt
- 10:33that I should throw myself into that from a research standpoint, to do what
- 10:37I can from a patient care standpoint, and as I said before, too,
- 10:41begin to train the next generation of black physicians to replace me at some
- 10:46point in time. So That's how the university over fourteen years. For family
- 10:52reasons, then for other reasons, I decided to go to work for Johnson
- 10:56Johnson in New Jersey just outside It's an area, and but still with a
- 11:03passion for research, and so we did that. It was, uh,
- 11:09it was a challenging transition because in my mind, I'm a doctor. I'm
- 11:13going to work in a biotech pharmaceutical area. I know what patients need,
- 11:20I have my own concepts as to what needs to be done, and I
- 11:24was totally on certain terms initially by my vice president Fitzroy, sit down and
- 11:28let me tell you something. You don't know what you don't know. So
- 11:35so it was a rough beginning for me, but over time I transitioned into
- 11:41doing more clinical research, still making the case that we need to do more
- 11:46for African Americans at all levels in terms of exposing them to clinical trials,
- 11:52recruit them to clinical trials, and to think about the diseases that are unique
- 11:56to African Americans. So I did that Johnson Johnson for eight and a half
- 12:01years. Then I went to a company called Insight in Wilmington, Delaware.
- 12:05I spent six years years and helped to develop a drug that is now approved
- 12:09for use. And then I went to work for a company in Boston in
- 12:16the pandemic twenty twenty remotely working on sickle cell disease and prostate cancer again,
- 12:24two major diseases in the African American community. And then in twenty twenty one,
- 12:31I took a break and then I began working for this company that I
- 12:33currently where I currently am as a consultant. Yeah, you know, Bravo,
- 12:39very commendable. So I wanted, like pre interview, I mentioned that
- 12:45I have a connection to the world of hematology and oncology. My wife actually
- 12:52is a sickle cell physician. We're based We're based in South Florida. She
- 12:56works at Memorial Hospital. Doctor yeah, doctor Joy at gusal A. Yeah,
- 13:03so that's that's my wife. Ye. So I hear every day just
- 13:09you know, the struggles of you know, advocating and trying to take care
- 13:13of the African American community when it comes to sickle cell. And then obviously
- 13:20you know that physician circle is kind of tight. So some of her closest
- 13:24friends one is an oncologist at Brady in Atlanta, Uh, doctor J Jones.
- 13:31So yeah, okay, yeah, so it's just like I said,
- 13:39I totally commend you for you know, all of the work, and so
- 13:43like my question is, like, just talk about how difficult it is not
- 13:48only to advocate for African Americans when it comes to getting these programs and you
- 13:56know, the research done, getting the approval you know, like from Johnson
- 14:01and Johnson, and you know, you know companies that kind of neglect us
- 14:09a lot of times, but also to gain the acceptance from the patients themselves,
- 14:18the patients to believe in the work that you're doing, the trust you
- 14:24with their bodies. Yes, and thanks for that. It's a great series
- 14:26of questions because that's in part one of the reasons why I wrote the book.
- 14:31So so so so thank you again so so for me. Having left
- 14:37Howard, I felt a little uneasy because I felt like I was leaving the
- 14:43patients behind. Right. The goal again in in my pursuit was to say,
- 14:50I can take youre one patient at a time, but if if we
- 14:52can be part of a story that helps you develop a drug, you could
- 14:58impact thousands of patients. So that was part of the conversation that I was
- 15:03having with my vice president. And one of the things that I realize is
- 15:07that very often. Once I got to the industry, the driving force was,
- 15:13yes, an interesting patience, but it was also a business. And
- 15:18so the question is, if we invest X of millions of dollars, will
- 15:26I get a return on my investment? Will I get a return on my
- 15:31investment for the investors, for the stockholders, what have you? And if
- 15:37you couldn't make that case, it was hard to move ahead, even though
- 15:41the need was there. So I don't know that I achieved a tremendous amount
- 15:46of success in that regard, because again I was relatively junior, sort of
- 15:50a mid level. I wasn't a vice president at the time or any of
- 15:54that sort of thing. So my voice in a company that was thousands of
- 16:00persons was minor. What has happened is that there is this resurgence, for
- 16:08example, in sickle cell disease drug development, and part of it is that
- 16:15there was an incentivization by the FD, incentivization by the government to say if
- 16:22these if you pursue these goals and these objectives, you will get certain perhaps
- 16:29tax breaks, what have you. So that's one one one initiative. The
- 16:34other initiative is that a big company, a huge company that makes I don't
- 16:41know, you know, ten billion dollars a year in sales. They may
- 16:48say to themselves, you know, sickle cell disease, and I'm using six
- 16:52disease as an example. We have one hundred thousand persons through United States,
- 16:57one hundred hundred and ten with sickle cell disease. Most of those patients are
- 17:03going to be on Medicaid, which doesn't pay quite as well as a private
- 17:11insurance, and they're making that calculation as to whether or not they want to
- 17:15go in that direction. So they may say to themselves, it's going to
- 17:21cost us too much to take that risk. What we will do is we
- 17:26will we will identify a small company as startup who has an interest in this
- 17:34area. We will fund them. Most of them are going to be unsuccessful,
- 17:41but if one of them is successful, we'll swoop in, we'll buy
- 17:45them, and we'll make will market the drug. So it's a question of
- 17:48de risking finances. And what has happened is again a little bit of history.
- 17:56In nineteen ninety two, a drug all hydroxcerea was approved for sickle cell
- 18:02disease, the first drug approved, and since then, for the next i'd
- 18:11say twenty years, nothing new had happened in sickle cell in terms of new
- 18:15drug development, and then suddenly, over the last five six years, there
- 18:19have been a tremendous amount of I think five or six compounds have been approved
- 18:26for six cell disease, with varying degrees of efficacy. And of course the
- 18:30other thing that you would know from talking to your wife and maybe your own
- 18:33research, is that this whole area of gene therapy has become a thing.
- 18:40Yeah, I was just about to mention that pretty exciting, pretty hyping stuff.
- 18:45And so so we've seen a seed change for different reasons that the industry
- 18:52is now beginning to look at this as a potential monetizing disease. Now I'm
- 18:59not so just all companies are like that, but I'm saying that there's a
- 19:03prevailing thought of we need to do good, but we also need to make
- 19:06money. Right. So that was part of the challenge that I didn't quite
- 19:10understand when I got the industry. I just thought, it's all about doing
- 19:14good and if we make the argument, then we should be good to go,
- 19:18right, all right, So, like to find the concept of good
- 19:22medicine in the context of clinical trials, like what role do you believe they
- 19:27play in revolutionize in cancer care. So that's a great question, and just
- 19:34give me a few minutes to sort of maybe develop the thought. Okay,
- 19:40I'll switch. I want country to pick a sickle cell disease. Let me
- 19:44switch to cancer. In the book that I wrote while at Howard University,
- 19:52I took care of quite a few patients who were afraid of cindericultures. They
- 19:59didn't want to hear the word because there's a long history associated with quote unquote
- 20:06research in the black community. And this particular person that I wrote about in
- 20:11the book came in to me with cancer of the pancreas. So we're still
- 20:18talking about the nineteen nineties, late nineteen nineties, maybe early two thousand and
- 20:23he was stage four and pancreatic cancer is just absolutely one of the worst diseases
- 20:30that you could possibly have. And I sat him down and I said,
- 20:34mister so and so, here's a story. You've got stage four pancreatic cancer.
- 20:41Here are my options or here are your options. Surgery is not going
- 20:45to do any good for you. Radiation therapy by itself is not going to
- 20:48do much for you. Chemotherapy, which is what you need at this point,
- 20:52is of limited value, consider the possibility of going on a clinical trial.
- 21:00And he said to me, doctor Dawkins, you know, I don't
- 21:07want to be a guinea pig. Whatever it is that you've been given to
- 21:11your other patients with pancreat cancer before, I am willing to take that because
- 21:18if it doesn't help anyone else, it will help me. So there is
- 21:22a belief without the facts that I was sharing with him. So why am
- 21:30I telling that story? Because in my view, clinical trials is good medicine
- 21:37when there is nothing better than what is considered to be the standard of care,
- 21:47or when the standard of care have run out and there's nothing else off
- 21:51of the patients except palliate with therapy. I think that the clinical trials gives
- 21:57you an opportunity to contribute to the progress of the next generation of treatments.
- 22:07So if you go for stage one clinical trial, the early stage, the
- 22:12questions being asked here are different. It's not the question typically is not is
- 22:18this is this new medication that has not been tested before in humans gonna cure
- 22:26me? We want to see if it how we can establish a safe dose
- 22:32to move it forward to the next stage. Is it too toxic? Is
- 22:36it, do we have the right dose? Do we need to move it
- 22:38on to stage two? But without getting into the granularities of the clinical trial,
- 22:47which I certainly would like to do. Mm hm. You are if
- 22:51you're not helping yourself by doing this, you are thinking down the road to
- 22:56the next generation, perhaps your kids all or your brother or your sister,
- 23:00where some of these answers will be obtained and it would be it would be
- 23:06useful for them even if it doesn't help you. And occasionally you do have
- 23:10early phase trials that have been I talk about that in the book as well,
- 23:14that have been very effective in terms of even curing some patients. So
- 23:19that's a very early stage where people really think about being a guinea pig or
- 23:22not want to participate. But they are also phase three trials where the drug
- 23:27has been proven to be safe and in the case of cancer, let's say
- 23:33pancreatic cancer, where the survival you know, five percent five year survival and
- 23:42that's optimistic. If there's a new drug out there that has been tested before
- 23:49and shows promise and you get put on that trial where you could be randomized
- 23:56to participate in that trial, you could potentially get from it an additional five
- 24:02months, six months, twelve months, We don't know, so that to
- 24:07me, investigating that arm is an important piece. And the last piece I'd
- 24:14say is that there are certain diseases that seem to be uniquely problematic cancers in
- 24:25the African American community. You take a disease something called multi moloma as an
- 24:30example. You take something called triple negative breast cancer. The rates among African
- 24:37Americans are twice as much as the white population, and we don't know for
- 24:44sure why that is. We just know that people die younger, they diagnosed
- 24:48earlier, and the treatments that have been developed may not be quite as effective
- 24:55for some of them. So the question is what is is there's something unique
- 25:00about these diseases as an example, that need new medications to increase the probability
- 25:07of cure. And so from that standpoint, I think helping ourselves by participating
- 25:12clinical trials, if not ourselves or families, and the next generation in my
- 25:17view is good meds. And the last thing I'd say are on good medicine
- 25:19is that when you're in a clinical trial, you get a tremendous amount of
- 25:26care that you probably would not have gotten going to see your regular doctor because
- 25:30everything has got to be documented, all the questions have got to be answered,
- 25:34all your side effects are assessed and so forth. So in that sense,
- 25:38you get really the best care when you're in a clinical job, right,
- 25:42Right, So obviously we know the historical context of the Tuskegee Experiment,
- 25:52and I'll say I have relatives that avoid going to the doctor at all costs,
- 26:00a great grandmother who never went until she passed away. And you know,
- 26:06there's there's other family members the same thing. They just they've they've heard
- 26:11or experienced situations where they felt like there was malpractice and you know, mistreatment.
- 26:21So just talk about what measures do you think should be taken to ensure
- 26:26the ethical conduct are these clinical trials? And the trust is built within our
- 26:33communities. So so again a great question, and saw it gets to the
- 26:37heart of the reason why I wrote the book. First of all, not
- 26:42to get too complex about it, but Tuskegee is called it Tuskegee Trial,
- 26:48Truskegee experiment, but in reality, Tuskegee was not a clinical trial in the
- 26:56sense that we understand it today. Tuskegee was a lie told to very specific
- 27:02set of people to get certain results. To make certain people famous and to
- 27:08give them information that will help the other and not the community that they were
- 27:15they entered into. So there was a lot of deception, There was a
- 27:17lot of lies, and there was it was not scientifically objective, okay,
- 27:23So and that messages hard to get across. The second piece is that a
- 27:30tremendous amount of change has occurred because of the suffering of African Americans and black
- 27:37people. When Tuskegee happened, it made the nation and the country go through
- 27:41a revolution in terms of how they think about this because they realized that something
- 27:47evil took place here. The nice thing about that, if you would,
- 27:51is that everybody benefited because of the disaster that took place of Tuskigee. Part
- 28:00of what I think we need to do is to tell the story that Tuskegee.
- 28:07The probability of Tuskegee happening again is substantially reduced because of the safety measures.
- 28:15You can sue if somebody is doing something unethical to you. You are
- 28:22allowed to ask questions. You are before you participate in clinicultural and informed consent
- 28:30is given to you which can be taken home, which can be discussed with
- 28:33your pastor can be discussed with your kids, can be discussed with whomever,
- 28:40and you have the right to ask questions about what it is and get that
- 28:45explained to you very well. So those are only some of the measures that
- 28:49have been taken since Tuskegee. The problem that I think that we're having is
- 28:56that the people who want to do these clinical trials don't necessarily feel themselves as
- 29:04part of the community. They don't necessarily see themselves, they see themselves as
- 29:11researchers, and so I think that there needs to be an attempt, a
- 29:18continuous attempt on the part of clinical trial is if you will to change that
- 29:26narrative, and I think one way to do that is to train people who
- 29:30look like the patients who were asked to part speaking the trial. I'm more
- 29:34likely to trust you because you look like me. I don't think you're lied
- 29:38to me, versus somebody who comes in wants you to sign a piece of
- 29:47paper, put you in a clinical trial, and don't see you again.
- 29:49So I think that there needs to be more training in the community. There
- 29:53needs to be a continuation of involvement in the community even after the clinical trials
- 30:00are done. Patients don't understand why a sponsor, a pharmaceutical company, a
- 30:08biotech company comes in, offers a clinical trial and when the results are over,
- 30:15they never see them again. The results are good, We're going to
- 30:21make some money out of this, and we'll see you. We won't see
- 30:26you again onto the next stime, and patients don't understand that. One of
- 30:30the ways that that is changing is the tax payer dollars that we pay to
- 30:38the government. Some of that goes to the National Institutes of Health, and
- 30:42the National Institutes of Health has bodies where they are funding investigators in their own
- 30:48community. People that the patients can trust, People that the patients see and
- 30:53know and understand physicians are mean and nursing, who can help them to break
- 31:00down to at their level exactly what they're being asked to do. And I
- 31:07think that there needs to be more of that. I think pharmaceutical companies need
- 31:11to spend more money in the community to build infrastructure for patients and to build
- 31:18the trust. I think the trust works both ways, right. I think
- 31:22patients are afraid many times, and I think the industry needs to reach out
- 31:29to them like they didn't COVID. They did that in COVID, but it
- 31:33was there's a tremendous amount of pressure on the pharmaceutical companies to have a more
- 31:37diverse patient population in their clinical trials to make it results more meaningful. And
- 31:44they began to do that, and I'm hoping that they won't pull back from
- 31:47that at this all, right, So, like, what what steps can
- 31:51they take to improve the recruitment efforts? I think I think one, as
- 31:56I said, they aren't there aren't as many African American physicians who are trained
- 32:04to do clinical trials. It's very rigorous, it's very specific, it's very
- 32:09data driven. There's something called good clinical practice that they need to be trained
- 32:15in, and they need to be available on a regular basis with the data
- 32:23to the companies that they work with. So I think that there needs to
- 32:27be more training. When I was at Howard, Pfizer and other companies took
- 32:34me to another city, sat me down for two days and said this is
- 32:38what a clinical trial looks like. Because I didn't get a lot of that
- 32:42in my own training. I got trained very well as an oncologist, but
- 32:46my experience as a clinical trialist and the rigor that is needed there, I
- 32:52didn't have as much of that. They took a bunch of us, and
- 32:54Sala said, here is what you need to do. So I think we
- 32:59need to train more doctors. We need to train more physicians, and I
- 33:02think we need to we need to the companies need to hire people internally who
- 33:09have these sensitivities and who can speak into into their into their existence because they're
- 33:20coming out of the same community. The representation representation at the highest level in
- 33:25farm or very often does not reflect the general population, and so I think
- 33:31that there has to be that. I think the boards need to be more
- 33:36diverse by because I may work for company X, but a lot of the
- 33:40things that I do is based on an executive level or a board level who
- 33:45says we're going to spend X amount of dollars and these are the these are
- 33:51the clinical trials we're going to do. My job, very often is to
- 33:54execute and not necessarily to ask a question. But if if they don't understand
- 34:00the community and what the needs are and what urgency is, then that will
- 34:05continue and be perpetuated unless somebody is in the boardroom to help them to understand
- 34:09exactly what's what what what what's needed. One of the encouraging things that I
- 34:15find is that there are a number of companies now black owned companies who are
- 34:22a business and their business is to help the pharmaceutical companies to understand what it
- 34:29means to go into a community, understand the community and how to recruit those
- 34:35patients. What does it take. Meetings with with with church leaders, meeting
- 34:40with community leaders, bringing people along, slowly identifying where the patients are that
- 34:46they need and what the patients need to participate. Sometimes a lot of a
- 34:52lot of African American patients say I want to participate in a clinical trial.
- 34:57I understand the significance of it, but you know, frankly, I have
- 35:01to work, and if you're expecting me to come in ten days, you
- 35:06know, you know, every day for the next ten days for clinical trial,
- 35:08I can't do it. So our transportation is an issue, or childcare
- 35:15is an issue, and a number of companies are now saying those don't have
- 35:19to be barriers. We can cover travel expenses, we can cover a number
- 35:23of these things to make it possible for you to participate in the clinicul trial.
- 35:30And I'd say, lastly, I part of what I wrote a book
- 35:34about is to say we need to make a lot more noise we need to
- 35:39be much more assertive about what our needs are and rather than being invited to
- 35:46participate in a clinicult trial, ask about them and not shy away from them
- 35:52because a lot of doctors, some doctors were looking and say, well,
- 35:55you know, my experience is that if this is an African American patient,
- 36:00they are going to tell me no, and it's going to be half an
- 36:04hour after I spent my time talking to them, and so I wouldn't even
- 36:08bother And that's an assumption of the apartment the patient would not botch. So
- 36:15the patient has to be proactive in that restricts m S right. Doctor Todd
- 36:21McClain provides Perio Timson undental implant services and two convenient locations. They offer over
- 36:25a decade of experience treating patients, and appointments can even be scheduled in the
- 36:30evenings, weekends or early mornings. Give the McCall in Chapel Hill at nine
- 36:34one, nine, five three, seven, ninety seven seventy four or Enduro
- 36:38at nine one, nine four eight four eighty three thirty eight, or visit
- 36:43them online and comes in implants dot Org. And I was gonna just say,
- 36:52you know, I just I guess having a front row seat to my
- 36:55wife's journey at the moment, I guess it's difficult for her to research practice
- 37:05and be a physical presence in the community. And like you said, there's
- 37:10a shortage of people of color in the field and the recruitment needs to be
- 37:19amped up tremendously. Yes. Yeah, but it doesn't have to be her
- 37:23alone. So one of the things that one of the cases we have made
- 37:25to the farm secret industry is it doesn't the doctor ultimately is responsible, but
- 37:35they can hire let's call him, ancillary personnel that can spend that time with
- 37:42the patient, hold the patient's hand, help them to understand, answer your
- 37:46questions, and after they get to a certain point, they come to your
- 37:51wife, and your wife says, all right, do you understand what was
- 37:53said? Do you understand what's on page six of the Long Informed Consent of
- 37:59you know, five pages, ten pages, twenty pages? Do you have
- 38:02any questions? You know, what is it that you need to understand?
- 38:07What is it that you're afraid of? Before you're willing to sign this consent?
- 38:10You need to take the content from and discuss it with your pastor.
- 38:14So it doesn't all have to be on your wife. But I also understand
- 38:17because I was at Howard and wearing five ten different hats, how difficult.
- 38:22That is, all right, cool, So let's just you know, as
- 38:30we prepare to wind down, just talk about the current role, you know,
- 38:34as a principal clinical consultant at Data Revive. I know you mentioned that
- 38:38you're at that stage where you're trying to shape them all the future. Just
- 38:43talk about that, and you know some of the breakthroughs and advancements that you're
- 38:46excited about when it comes to some of this treatment. Well, first Data
- 38:53Revive my role is shifted a little bit. So I'm a consultant now,
- 38:59and I'm a consultant to a lot of companies that are either in the United
- 39:07States or China where they have new compounds, new drugs that they're trying to
- 39:15get through the regulatory process through the FDA. And so I am not as
- 39:23much, say as when I was at J ANDJ involved in actually executing and
- 39:30monitoring the trials as I was before. But one of the things that I've
- 39:35done is because of some initiative on the FDA's part which says, now that
- 39:44if you're going to do a trial in the United States, wherever you're from,
- 39:47China, India, you know, Europe, whatever, you have got
- 39:52to guarantee a percentage. It's not a quota, but it's saying that you
- 40:00must address this issue of diversity. You cannot continue to have ninety of your
- 40:07patients being white and then get positive results and then say, well it's positive.
- 40:15So it applies to everyone. And one of the things that I've had
- 40:17the opportunity to do is to write a blog that is going to go up
- 40:22in China on your travel heard of something called we chat that's the equivalent there,
- 40:30that talks about the need for diversity, even if they come from China,
- 40:37the need for diverse near clinical trials, and what kinds of things they
- 40:40need to do to ensure that their clinical trial recruitment is diverse, because if
- 40:47they don't, the agency has sort of flipped the script and Salla said,
- 40:52we no longer are going to just allow you to walk in and get your
- 40:55drug approved. You've got to show some hard evidence of what you did,
- 41:00how you did it, and how many patients are involved in this process.
- 41:06So it's a message that I continue to to to preach, if you would,
- 41:09even though my role has has changed somewhat so in terms of things that
- 41:15have changed. Certainly, we talked at the top of the top of the
- 41:19half an hour or so about how sickle cell disease has has changed, the
- 41:23treatment for sickle cell disease has changed. You know. One of the things
- 41:30that I'm very excited about, and I mentioned in the book is the vaccine
- 41:35against a virus called HPV virus, which is the number one reason for cervical
- 41:44cancer. Right. That took a long time to come to birth. But
- 41:49I'm very excited about that because it's about prevention. It's about preventing a disease
- 41:55that is most likely to happen if the virus is not stopped. Right.
- 42:01So that is something that I find very exciting, and I'm continuing to think
- 42:09more so. I'm an oncologist, right, So I'm the guy you come
- 42:13to see, or you used to come to see when I was at Howard
- 42:16after the disease had left from stage one and has gone to stage four metastatic
- 42:23disease, right, And I know I can help you, but I can
- 42:27only help you so much. The thing for me is more and more and
- 42:32more about prevention. We worked on a drug when I was at Howard for
- 42:39preventing breast cancer. And I'm very proud of that study because the drug eventually
- 42:47got approved by the FDA as a cancer prevention for breast cancer. It had
- 42:53some issues, it had some side effects, but it did work and show
- 42:59that if you at risk for breast cancer, if you follow the certain categories
- 43:02of breast cancer, you can actually reduce that rate by by fifty percent if
- 43:12you take if you take the drug. The other area of excitement I think
- 43:17is something called Crisper, where they're now using this new technology. It's not
- 43:23new anymore, but they can actually use this technology like a pair of scissors,
- 43:31and if your disease is genetically based, you can actually use this biologic
- 43:37platform to snip out the gene that may be associated with that disease, and
- 43:44so so you don't have that disease anymore or your risk of developing that anymore.
- 43:49And I think that that's going to revolutionize things because now as long as
- 43:52you can show that the gene is clearly associated with disease X, you can
- 44:00actually remove that. So ultimately you may never need to see a guy like
- 44:05a medical ancologist to treat your stage four. So your revolution is taking place.
- 44:09We understand now what cancer is much more than we did fifty years ago.
- 44:15There's tremendous advancement in prostate cancer, even lung cancer, which is the
- 44:22big killer in African American community. There are data showing now that if you
- 44:30identify the disease early enough using certain cat scan procedures screening with a cat scan,
- 44:37you can pick up disease a lot earlier, and you can you can
- 44:42surgically remove the lesion that you see long before the patient even realize that they
- 44:45have symptoms, and then that disease is unlikely to become a problem somewhere down
- 44:52the road. So if you hear me talking more about risk reduction, cancer
- 44:59risk reduction, and cancer prevention, that is where I think the research needs
- 45:05to go. And I think that more and more patience are saying that why
- 45:10are you chasing the horse after the horse's after this gone through the barn door,
- 45:15It's hard to bring them back. Why don't you shut the barn door
- 45:19with preventive measures. The problem for me is that a lot of African Americans
- 45:24will not even begin to think and talk about that because either one they have
- 45:31no symptoms are two they don't want to know, and they are afraid,
- 45:37and they put a head in the sand and until it becomes too late.
- 45:43So okay, all right, So Dotta Dawkins, what do you find most
- 45:49rewarding in your career. I find it very rewarding that I believe that I
- 45:57have made an impact on the community in terms of my practice, in terms
- 46:04of my advocacy and having a platform for the advocacy. And to be honest
- 46:09with you, I'm kind of wind out my career in many ways. And
- 46:15the book that I've written here I found very satisfying because it forced me to
- 46:21think through and put down on paper some of the thoughts that I've had for
- 46:29thirty plus years. It forced me to that year of hiatus that I said
- 46:35I had between Boston and Satin. This new job. It forced me to
- 46:38put down on paper some of my hope, some of my dreams of what
- 46:44I would like to see in African American community. And I'm hoping that a
- 46:47book like this will get read in the community and that it will move people,
- 46:53and that we will begin to turn the ship so that we begin to
- 46:59feel not outsiders, but we are. We are Americans, and everything that
- 47:07is due to any American is due to us, and so we need to
- 47:10go grab it and take it. Just like we did with the civil civil
- 47:15rights movement. We weren't shy about that. We weren't shy about playing sports.
- 47:20We dominate a number of sports right now, and I think we need
- 47:23to sort of have that same attitude in terms of all healthcare, not to
- 47:29hide our head in the sand, but to face it head on and demand
- 47:35and seize the day, if you would. So, I have no regrets
- 47:38in looking back about your first question was what drove me as a boy in
- 47:45Jamaica to become a physician. I'm very thankful that this country has give me
- 47:51that opportunity, and I would like to believe that I did not waste the
- 47:54opportunity. Okay, so m plug the book, you know, just briefly
- 48:02tell us about some of the good medicine in the book where we can find
- 48:06it, and then where we can find you on social media. So the
- 48:12book is fighting for survival, conquering cancer and the African American patient, And
- 48:23what I write in there, I use my personal story off off of of
- 48:30identifying with an African community which I did not grow up with in my in
- 48:37my early years, but I used my personal story of struggle, the racism
- 48:42that I faced in in in Buffalo, the Confederate flag, guys who stopped
- 48:47me on the street at two o'clock in the morning and threatened me, the
- 48:52the the the the people who painted my car nigger. And I'm saying I'm
- 49:00not telling the story because I'm vain. I'm telling the story to say that
- 49:04despite all of that, despite all of that, you can come through,
- 49:08and you've got to put things in perspective. So that's one of the reasons
- 49:12why I told the story. In the story in the book, I talk
- 49:16about people with hope. There is a woman, young woman who's as far
- 49:23as I know, is still alive, who had leukemia, pride and joy
- 49:29of her West African parents at the university in Washington, DC, who had
- 49:35leukemia, and who was kicked out of the hospital that should have admitted her
- 49:37to our hospital. And she flouted me tooth and nail. She didn't even
- 49:43think I knew what I was doing. She literally said that to me,
- 49:45a nineteen year old, do you know what you're doing? Because I was
- 49:49so sick from the treatment, and she survived, She survived to get married
- 49:53and have children after two years of treatment. It's a story about about a
- 50:00young woman from South Asia who kept telling people she got abdominal pain. She
- 50:08went to the murderenisty room. She said, they told her she had peptic
- 50:15ulcers, stomach ulcers, and she says, you know, my sister died
- 50:19at thirty two years old ato aaron cancer in my old country. Do you
- 50:22think this is what it could be? And they said, no, take
- 50:25this medicine and call the doctor in the morning. She went to a second
- 50:30emergency room with the same complaint and they gave her the same story. She
- 50:35came to Howard University emergency room and complained of the same thing the central gastinentrologists
- 50:40and the gaser intrologist said to me, Fitzroy, this lady doesn't have stomach
- 50:46cancer, she doesn't have stomach ulcers. She has something else. It turned
- 50:51out at at thirty two years old, she had ovarian cancer stage three of
- 50:58Aarren cancer. And the story for me is multifold one. She insisted,
- 51:07based on her family history that there is something else going on here and you
- 51:13need to take care of the fact that my sister dad at a young age
- 51:17around the age that she was at that time, so she knew her family
- 51:22history. And so part of my plea to the African American community is we
- 51:25need to talk to each other about what our history is, not just Tuskegee,
- 51:30what a medical history is, because it could be genetically driven. And
- 51:35you need to share that information with your kids. You need to share that
- 51:37information with your cousins. You need to talk about them, not ignore it.
- 51:43The other part for me is that this woman is still alive twenty five
- 51:46years later. Twenty five years later with a stage three of Aaron cancer.
- 51:52She reaches out to me every Christmas and sents me gift. She's alive.
- 51:58And I think if she was not advocating, which is the other word I
- 52:00want to throw it there, if she was not advocating for herself, she
- 52:06may not be alive today. So knowing your history, sharing your history,
- 52:12and knowing your body and knowing that something more than what you're being told is
- 52:16going on is an important part of the conversation. And lastly, you know,
- 52:22talk to talk to your physician, talk to them. I spent a
- 52:24tremendous amount of time with her on the phone after she she got chemotherapy her
- 52:29her her her toes were hurting because she had something called neuropathy. She was
- 52:34vomiting, she lost her hair, but she stuck with it. She stuck
- 52:37with it and she survived. So I'm speaking about self advocacy, and I'll
- 52:45give you another tear jerker story. You know, since since you asked.
- 52:51Another woman, elderly woman sixty plus I think she was at the time,
- 52:57was told she came from the Islands to visit her daughter and she said she
- 53:02had a clean bit of health by the doctor there. And she came to
- 53:07the States because her first grandchild was about to be born. And to this
- 53:12day, I still get very emotional about that. And she went to see
- 53:16a doctor in Washington, d C. And the doctor says, I think
- 53:22you have overn cancer. And she says, they gave me a clean bit
- 53:27of health two months ago. What do you mean? She comes to me
- 53:32to Howard and we look at her. We got a biopsy. In fact,
- 53:37she had ovarian cancer, and in fact it was stage four of aron
- 53:43cancer. And when we decided how we're going to treat her, the surgeons
- 53:49and myself and others the team, she looked at me and she says,
- 53:54doctor Dawkins, I'm I going to live to see my first grandchild. And
- 54:01I said to her, I don't know, but I will do the best
- 54:07I can for you. And she lived. She lived to see her first
- 54:12grandchild, she lived to see her second grandchild, and after four years after
- 54:16diagnosis, unfortunate she passed away. But for me, that's a success.
- 54:21That is something that says stick with it, work with the doctors, ask
- 54:27questions, self, advocate, and get the best care that you can by
- 54:30whatever means necessary. Wow. All right, that's so powerful and point out
- 54:39way to In this week's episode of Stop Looking Listen, Yeah, know your
- 54:46history, share your history, advocate and you know, communicate with your physician.
- 54:54Doctor Dawkins, it's been a pleasure just to sit in send and learn
- 55:00you know, from you and you know, just give us hope for you
- 55:05know, some of the trauma as a people that we faced and that we
- 55:12can overcome it, you know, with people like you, you know,
- 55:15fighting a good fight. Make sure make sure you pick up his book Fighting
- 55:22for Survival, Conquering Cancer and the African American Patient, available now and for
- 55:29Stop Looking Listen. I'm your host, Detroit Gardner. See you next week.
- 55:34Peace and blessings,